⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JSPR News
Jasper Therapeutics, Inc. Common Stock
Pomerantz LLP Announces Commencement of Class Action Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
JSPR
JSPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
JSPR
Pomerantz LLP Announces Class Action Litigation Filing Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
Pomerantz LLP Announces Securities Class Action Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In JSPR To Contact Him Directly To Discuss Their Options
prnewswire.com
JSPR
Pomerantz LLP Announces Commencement of Class Action Lawsuit Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
JSPR
JSPR Deadline: JSPR Investors with Losses in Excess of $100K Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
JSPR
Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
JSPR